Omega Therapeutics, Inc.

CIK 1850838 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Omega Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Mar 31, 202515-12G0001193125-25-068757
Mar 25, 2025EFFECT9999999995-25-000753
Mar 21, 2025S-8 POS0001193125-25-060207
Mar 21, 2025POS AM0001193125-25-060215
Mar 20, 2025250001193125-25-058964
Mar 7, 2025SCHEDULE 13G/A0000315066-25-000984
Feb 24, 20258-K0001193125-25-033500
Feb 14, 20258-K0001193125-25-027349
Feb 5, 20251440001969223-25-000030
Feb 5, 2025SCHEDULE 13D/A0000950170-25-014583
Feb 5, 2025SCHEDULE 13D/A0000950170-25-014583
Feb 5, 20251440001969223-25-000030
Feb 4, 202530000950170-25-014107
Feb 3, 20258-K0001193125-25-019359
Jan 28, 20258-K0001193125-25-014403
Jan 17, 20258-K0001193125-25-008477
Jan 10, 20258-K0001193125-25-004507
Dec 31, 20248-K0001193125-24-287201
Dec 31, 2024SCHEDULE 13D/A0000950170-24-141669
Dec 6, 20248-K0001193125-24-272532
Dec 5, 202440000950170-24-133679
Dec 5, 202430000950170-24-133667
Nov 26, 202440000950170-24-131188
Nov 26, 202430000950170-24-131182
Nov 15, 202440000950170-24-127720